keyword
https://read.qxmd.com/read/38631030/evaluating-the-disease-related-experiences-of-tiktok-users-with-lupus-erythematosus-qualitative-and-content-analysis
#1
JOURNAL ARTICLE
Lindsey J Wanberg, David R Pearson
BACKGROUND: Lupus erythematosus (LE) is an autoimmune condition that is associated with significant detriments to quality of life and daily functioning. TikTok, a popular social networking platform for sharing short videos, provides a unique opportunity to understand experiences with LE within a nonclinical sample, a population that is understudied in LE research. This is the first qualitative study that explores LE experiences using the TikTok platform. OBJECTIVE: This study aims to evaluate the disease-related experiences of TikTok users with LE using qualitative and content analysis...
April 17, 2024: JMIR Infodemiology
https://read.qxmd.com/read/38630952/case-control-study-of-individuals-with-small-fiber-neuropathy-after-covid-19
#2
JOURNAL ARTICLE
Lindsay McAlpine, Adeel S Zubair, Phillip Joseph, Serena Spudich
OBJECTIVES: To report a case-control study of new-onset small fiber neuropathy (SFN) after COVID-19 with invasive cardiopulmonary exercise testing (iCPET). SFN is a critical objective finding in long COVID and amenable to treatment. METHODS: A retrospective chart review was conducted on patients seen in the NeuroCOVID Clinic at Yale who developed new-onset SFN after a documented COVID-19 illness. We collected demographics, symptoms, skin biopsy, iCPET testing, treatments, and clinical response to treatment or no intervention...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38630073/-wakefulness-promoting-agents-for-severe-fatigue-to-use-or-not-to-use
#3
JOURNAL ARTICLE
Laura E De Wit, Roeland Vis, Laurien L Teunissen
About 20% of adults experience excessive daytime sleepiness or severe fatigue. Causes include somatic conditions, psychiatric disorders, and medication or drug use. Treatment depends on the underlying cause. If sleepiness persists despite optimal treatment of the underlying condition, exclusion of other causes, and behavioral interventions, wakefulness-promoting agents may be considered. However, no established pharmacological strategy exists for symptomatic treatment. Modafinil and stimulants like methylphenidate may offer some benefit based on experiences with narcolepsy or idiopathic hypersomnia...
April 16, 2024: Nederlands Tijdschrift Voor Geneeskunde
https://read.qxmd.com/read/38627327/cluster-analysis-of-long-covid-symptoms-for-deciphering-a-syndrome-and-its-long-term-consequence
#4
JOURNAL ARTICLE
J Niewolik, M Mikuteit, S Klawitter, D Schröder, A Stölting, K Vahldiek, S Heinemann, F Müller, Gmn Behrens, F Klawonn, A Dopfer-Jablonka, S Steffens
The long-term symptoms of COVID-19 are the subject of public and scientific discussions. Understanding how those long COVID symptoms co-occur in clusters of syndromes may indicate the pathogenic mechanisms of long COVID. Our study objective was to cluster the different long COVID symptoms. We included persons who had a COVID-19 and assessed long-term symptoms (at least 4 weeks after first symptoms). Hierarchical clustering was applied to the symptoms as well as to the participants based on the Euclidean distance h of the log-values of the answers on symptom severity...
April 16, 2024: Immunologic Research
https://read.qxmd.com/read/38611624/long-covid-long-term-impact-of-sars-cov2
#5
REVIEW
Huda Makhluf, Henry Madany, Kenneth Kim
Four years post-pandemic, SARS-CoV-2 continues to affect many lives across the globe. An estimated 65 million people suffer from long COVID, a term used to encapsulate the post-acute sequelae of SARS-CoV-2 infections that affect multiple organ systems. Known symptoms include chronic fatigue syndrome, brain fog, cardiovascular issues, autoimmunity, dysautonomia, and clotting due to inflammation. Herein, we review long COVID symptoms, the proposed theories behind the pathology, diagnostics, treatments, and the clinical trials underway to explore treatments for viral persistence, autonomic and cognitive dysfunctions, sleep disturbances, fatigue, and exercise intolerance...
March 28, 2024: Diagnostics
https://read.qxmd.com/read/38610117/the-personal-impact-of-living-with-a-myeloproliferative-neoplasm
#6
JOURNAL ARTICLE
A A M Eppingbroek, L Lechner, E C Bakker, M D Nijkamp, M A de Witte, C A W Bolman
OBJECTIVE: The aim of this study is to gain insight into the physical, psychological and social impact of having a myeloproliferative neoplasm (MPN), a rare type of cancer with an often chronic course. METHODS: An online survey was conducted among 455 Dutch MPN patients (62.7% female, age M 63) to explore the impact of the disease by measuring the MPN symptom burden (MPN-SAF TSS) and quality of life (QoL) (EORTC QLQ-C30) and its subscales within a hierarchical QoL model...
April 2024: Psycho-oncology
https://read.qxmd.com/read/38605969/the-gastrointestinal-microbiota-in-the-development-of-me-cfs-a-critical-view-and-potential-perspectives
#7
REVIEW
Andreas Stallmach, Stefanie Quickert, Christian Puta, Philipp A Reuken
Like other infections, a SARS-CoV-2 infection can also trigger Post-Acute Infection Syndromes (PAIS), which often progress into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS, characterized by post-exercise malaise (PEM), is a severe multisystemic disease for which specific diagnostic markers or therapeutic concepts have not been established. Despite numerous indications of post-infectious neurological, immunological, endocrinal, and metabolic deviations, the exact causes and pathophysiology remain unclear...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38603918/psychological-flexibility-in-somatic-symptom-and-related-disorders-a-case-control-study
#8
JOURNAL ARTICLE
René J D M Selker, Tim Y Koppert, Jan H Houtveen, Rinie Geenen
A key diagnostic criterion of Somatic Symptom and related Disorders (SSD) comprises significant distress and excessive time-and-energy consuming thoughts, feelings, and behavior pertaining to somatic symptoms. This diagnostic criterion is lacking in central sensitivity syndromes (CSS), such as fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome. This strong emphasis on disturbed psychological processing of somatic symptoms, suggests that psychological flexibility is low in SDD. Psychological flexibility is defined as the ability to approach difficult or challenging internal states (thoughts, emotions, and bodily sensations) in a non-judgmental, mindful way, and being committed to pursue one's values...
March 28, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38602675/physician-empathy-and-chronic-pain-outcomes
#9
JOURNAL ARTICLE
John C Licciardone, Yen Tran, Khang Ngo, David Toledo, Navya Peddireddy, Subhash Aryal
IMPORTANCE: Empathy is an aspect of the patient-physician relationship that may be particularly important in patients with chronic pain. OBJECTIVE: To measure the association of physician empathy with pain, function, and health-related quality of life (HRQOL) among patients with chronic low back pain. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included adult enrollees from the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation national pain research registry...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38599650/association-of-clinical-response-criteria-and-disease-activity-levels-with-axial-spondyloarthritis-core-domains-results-from-two-phase-3-randomised-studies-be-mobile-1-and-2
#10
JOURNAL ARTICLE
Victoria Navarro-Compán, Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, Marina Magrey
OBJECTIVE: To assess how achievement of increasingly stringent clinical response criteria and disease activity states at week 52 translate into changes in core domains in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA). METHODS: Patients in BE MOBILE 1 and 2 achieving different levels of response or disease activity (Assessment of SpondyloArthritis International Society (ASAS) and Ankylosing Spondylitis Disease Activity Score (ASDAS) response criteria, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI50)) at week 52 were pooled, regardless of treatment arm...
April 10, 2024: RMD Open
https://read.qxmd.com/read/38595276/factors-associated-with-distress-related-to-perceived-dignity-in-patients-with-rheumatic-diseases
#11
JOURNAL ARTICLE
Virginia Pascual-Ramos, Irazú Contreras-Yáñez, Maximiliano Cuevas-Montoya, Guillermo Arturo Guaracha-Basañez, Mario García-Alanis, Oscar Rodríguez-Mayoral, Harvey Max Chochinov
BACKGROUND: The loss of perceived dignity is an existential source of human suffering, described in patients with cancer and chronic diseases and hospitalized patients but rarely explored among patients with rheumatic diseases (RMDs). We recently observed that distress related to perceived dignity (DPD) was present in 26.9% of Mexican patients with different RMDs. The study aimed to investigate the factors associated with DPD. METHODS: This cross-sectional study was performed between February and September 2022...
April 10, 2024: Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases
https://read.qxmd.com/read/38593202/the-role-of-exercise-training-on-cardiovascular-risk-factors-and-heart-disease-in-patients-with-chronic-kidney-disease-g3-g5-and-g5d-a-clinical-consensus-statement-of-the-european-association-of-preventive-cardiology-eapc-of-the-esc-and-the-european-association
#12
JOURNAL ARTICLE
Evangelia Kouidi, Henner Hanssen, Kirsten Anding-Rost, Adamasco Cupisti, Asterios Deligiannis, Clemens Grupp, Pelagia Koufaki, Paul Leeson, Eva Segura-Orti, Amaryllis Van Craenenbroeck, Emeline Van Craenenbroeck, Naomi Clyne, Halle Martin
Cardiovascular (CV) morbidity and mortality is high in patients with chronic kidney disease (CKD). Most patients reveal a high prevalence of CV risk factors such as diabetes or arterial hypertension and many have manifest cardiovascular disease (CVD), such as coronary artery disease and chronic heart failure with an increased risk of clinical events including sudden cardiac death. Diabetes mellitus and hypertension contribute to the development of CKD and the prevalence of CKD is in the range of 20%-65% in diabetic and 30%-50% in hypertensive patients...
April 9, 2024: European Journal of Preventive Cardiology
https://read.qxmd.com/read/38586640/drug-induced-autoimmune-hepatitis-an-unusual-adverse-event-of-atorvastatin-therapy
#13
Mitwa Patel, Abdul Fattah, Helai Hussaini, Fnu Maneesha, Zahoor Ahmed
Drug-induced autoimmune hepatitis (AIH) is characterized by acute or chronic hepatic injury coupled with autoantibody development, hypertransaminasemia, and idiopathic AIH features on liver biopsy. Atorvastatin-induced AIH is a rare but well-documented life-threatening adverse event. We report a case of atorvastatin-induced AIH in a 57-year-old female who presented with worsening fatigue, jaundice, and deranged liver function tests. She had been prescribed atorvastatin 20 mg daily three months prior. Her clinical presentation, imaging findings, and serological testing were suggestive of drug-induced AIH...
March 2024: Curēus
https://read.qxmd.com/read/38579861/hsr24-164-predicting-treatment-related-fatigue-in-the-context-of-lymphoma-and-chronic-lymphocytic-leukemia
#14
JOURNAL ARTICLE
Steve E Kalloger, Amanda Watson, Shawn Sajkowski, Natacha Bolaños, Lorna Warwick
No abstract text is available yet for this article.
April 5, 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38578435/effects-of-an-integrative-multimodal-inpatient-program-on-fatigue-and-work-ability-in-patients-with-post-covid-syndrome-a-prospective-observational-study
#15
JOURNAL ARTICLE
Sarah Schmid, Christine Uecker, Antje Fröhlich, Jost Langhorst
Post-COVID syndrome (PCS) is characterized by a variety of non-specific symptoms. One of the leading symptoms is fatigue. So far, there is no evidence-based causal therapy established and treatment of PCS is primarily symptom-oriented. The Clinic for Internal and Integrative Medicine in Bamberg, Germany, offers a comprehensive multimodal integrative inpatient therapy for PCS patients. Within a prospective uncontrolled observational study, the results of N = 79 patients were analysed. Post-COVID fatigue patients were hospitalized for up to 14 days...
April 5, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38576235/effectiveness-of-korean-red-ginseng-on-fatigue-in-patients-with-rheumatic-diseases-a-randomized-double-blind-placebo-controlled-study
#16
JOURNAL ARTICLE
Soo-Kyung Cho, Yeo-Jin Song, Jung-Yong Han, Hye Won Kim, Eunwoo Nam, Yoon-Kyoung Sung
BACKGROUND: To evaluate the effectiveness of Korean Red Ginseng (KRG) in managing fatigue in Korean patients with rheumatic diseases. METHODS: Patients were randomly assigned to KRG (2 g/day, n = 60) or placebo (n = 60) groups for 12 weeks of blind phase and then open-label KRG from weeks 12 to 24 (placebo-KRG, continuous-KRG). The primary outcome was the improvement rate in fatigue, defined by an increase in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scores at 12 weeks...
April 5, 2024: Korean Journal of Internal Medicine
https://read.qxmd.com/read/38576058/impact-assessment-of-integrated-pathy-on-cancer-related-fatigue-in-cancer-patients-an-observational-study
#17
JOURNAL ARTICLE
Acharya Balkrishna, Prashant Katiyar, Sourav Ghosh, Sumit Kumar Singh, Vedpriya Arya
BACKGROUND: Integrated-pathy aims to integrate modern medicine with traditional systems via applying the holistic approach of Ayurveda, Yoga, and natural medicine. This is important for addressing the challenges surrounding the delivery of long-term palliative care for chronic ailments including cancer. The prime intent of this study was to substantiate the underlying hypothesis behind the differential and integrative approach having a positive impact on Quality of Life of cancer patients...
April 4, 2024: Journal of Health, Population, and Nutrition
https://read.qxmd.com/read/38573482/safety-and-efficacy-of-pegcetacoplan-in-adult-patients-with-paroxysmal-nocturnal-hemoglobinuria-over-48%C3%A2-weeks-307-open-label-extension-study
#18
JOURNAL ARTICLE
Christopher J Patriquin, Andrija Bogdanovic, Morag Griffin, Richard J Kelly, Jaroslaw P Maciejewski, Brian Mulherin, Régis Peffault de Latour, Alexander Röth, Veena Selvaratnam, Jeffrey Szer, Mohammed Al-Adhami, Regina Horneff, Lisa Tan, Michael Yeh, Jens Panse
INTRODUCTION: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life-threatening disease characterized by complement-mediated hemolysis and thrombosis. Pegcetacoplan, the first targeted complement component 3 (C3) PNH therapy, was safe and efficacious in treatment-naive and pre-treated patients with PNH in five clinical trials. METHODS: The 307 open-label extension (OLE) study (NCT03531255) is a non-randomized, multicenter extension study of long-term safety and efficacy of pegcetacoplan in adult patients with PNH who completed a pegcetacoplan parent study...
April 4, 2024: Advances in Therapy
https://read.qxmd.com/read/38571671/a-case-of-chronic-kidney-disease-patient-with-rapid-deterioration-of-renal-function-hair-loss-and-spontaneous-resolution-of-facial-warts-after-covid-19-infection
#19
Qishun Wu, Fei Gao, Tao Zhang, Shixi Zhang, Yun Bai, Bei Zhu, Lulu Guo, Zhenzhu Yong, Weihong Zhao, Xiaohua Pei
BACKGROUND: Individuals with pre-existing chronic kidney disease (CKD) are at an increased risk of experiencing severe symptoms if infected with COVID-19. This report presents the case of a patient with CKD who contracted COVID-19 and subsequently experienced rapid deterioration of kidney function, hair loss, and spontaneous remission of facial warts. CASE PRESENTATION: A 60-year-old Chinese man with a decade-long history of abnormal serum creatinine (Scr) levels and recently heightened fatigue sought treatment...
February 2024: Aging medicine
https://read.qxmd.com/read/38570861/5-epifat-trial-protocol-a-multi-center-randomized-placebo-controlled-trial-of-the-efficacy-of-pharmacotherapy-for-fatigue-using-methylphenidate-bupropion-ginseng-and-amantadine-in-advanced-cancer-patients-on-active-treatment
#20
JOURNAL ARTICLE
Mojtaba Miladinia, Mina Jahangiri, Sharon Jackson White, Hossein Karimpourian, Alessandro Inno, Sally Wai-Chi Chan, Reza Ganji, Mahmood Maniati, Kourosh Zarea, Marziyeh Ghalamkari, Ali Farahat, Cecilia Fagerström
BACKGROUND: Cancer-related fatigue (CRF) is still undertreated in most patients, as evidence for pharmacological treatments is limited and conflicting. Also, the efficacy of the pharmacological agents relative to each other is still unclear. Therefore, medications that may potentially contribute to improving CRF will be investigated in this head-to-head trial. Our main objective is to compare the efficacy of methylphenidate vs. bupropion vs. ginseng vs. amantadine vs. placebo in patients with advanced cancer...
April 3, 2024: Trials
keyword
keyword
67257
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.